Trial Profile

Multiple ascending dose study of extended-release oral formulation of EV-077.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Jul 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SER 150 (Primary)
Indications Cardiovascular disorders; Thrombosis
Focus Adverse reactions

Most Recent Events

15 Jul 2011 Status changed from recruiting to completed, according to information in an Evolva media release.
16 Dec 2010 New trial record
16 Dec 2010 This study is expected to be completed in the first half of 2011, according to an Evolva media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com